Profil
Tracy Cunningham is currently the Director at Health Research Board and the Chief Medical Officer at Amryt Pharma Plc.
Previously, she worked as the Clinical Head-Oncology Research & Development at AstraZeneca PLC and as the Vice President & Head-Development at Amryt Pharma Holdings Ltd. Dr. Cunningham completed her undergraduate degree at the Royal College of Surgeons.
Postes actifs de Tracy Cunningham
| Sociétés | Poste | Début |
|---|---|---|
| AMRYT PHARMA PLC | Directeur Technique/Scientifique/R&D | 01/04/2020 |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Directeur/Membre du Conseil | - |
Anciens postes connus de Tracy Cunningham
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Directeur Technique/Scientifique/R&D | - |
Formation de Tracy Cunningham
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Royal College of Surgeons
Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Government |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
















